Literature DB >> 7689621

A rapid and highly selective approach to cell separations using an immunomagnetic colloid.

J P Hancock1, J T Kemshead.   

Abstract

Immunomagnetic colloids have the properties of solutions and, therefore, offer distinct advantages in their ability to bind to cells as compared to larger magnetic microspheres. B cells and T cells have been isolated with higher degrees of purity following incubation with monoclonal antibodies (MoAbs) and a goat anti-mouse Ig ferrofluid. This was demonstrated both with mixtures of cell lines and lines titrated into normal bone marrow. In all cases, low non-specific binding was observed. Maximal cell capture was obtained without washing out excess MoAb, resulting in cell separations that could be completed in under 30 min. The system permits not only the magnetic capture of cells onto pins in a high gradient separator, but also their recovery. Cells separated in this way appear to be highly viable and it is possible to manipulate them further as the immunocolloid is sufficiently small for it not to interfere with tests such as indirect immunofluorescence. The advantages and disadvantages of immunocolloids versus larger magnetic microspheres are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689621     DOI: 10.1016/0022-1759(93)90275-c

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Differential interaction of magnetic nanoparticles with tumor cells and peripheral blood cells.

Authors:  J H Clement; M Schwalbe; N Buske; K Wagner; M Schnabelrauch; P Görnert; K O Kliche; K Pachmann; W Weitschies; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-24       Impact factor: 4.553

2.  The artificial peroxidase activity of magnetic iron oxide nanoparticles and its application to glucose detection.

Authors:  Faquan Yu; Yongzhuo Huang; Adam J Cole; Victor C Yang
Journal:  Biomaterials       Date:  2009-06-09       Impact factor: 12.479

3.  Circulating tumor cells: clinically relevant molecular access based on a novel CTC flow cell.

Authors:  Jessamine P Winer-Jones; Behrad Vahidi; Norma Arquilevich; Cong Fang; Samuel Ferguson; Darren Harkins; Cory Hill; Erich Klem; Paul C Pagano; Chrissy Peasley; Juan Romero; Robert Shartle; Robert C Vasko; William M Strauss; Paul W Dempsey
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.